Overall survival with osimertinib in untreated NSCLC
- PMID: 31787537
- DOI: 10.1016/S1470-2045(19)30778-8
Overall survival with osimertinib in untreated NSCLC
Comment on
-
Overall Survival with Osimertinib in Untreated, EGFR-Mutated Advanced NSCLC.N Engl J Med. 2020 Jan 2;382(1):41-50. doi: 10.1056/NEJMoa1913662. Epub 2019 Nov 21. N Engl J Med. 2020. PMID: 31751012 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous
